Molecular docking of 5-phenyl-5,6-dihydrotetrazolo-[1,5-c]quinazolines to ribosomal 50s protein L2P (2QEX
| dc.contributor.author | Antypenko, O. M. | |
| dc.contributor.author | Antypenko, L. | |
| dc.contributor.author | Kalnysh, D. | |
| dc.contributor.author | Kovalenko, S. I. | |
| dc.contributor.author | Антипенко, Олексій Миколайович | |
| dc.contributor.author | Коваленко, Сергій Іванович | |
| dc.date.accessioned | 2022-11-03T12:37:52Z | |
| dc.date.available | 2022-11-03T12:37:52Z | |
| dc.date.issued | 2022 | |
| dc.description | Antypenko O. M. - https://orcid.org/0000-0002-8048-445X; Kovalenko S. I. - https://orcid.org/0000-0001-8017-9108. | uk_UK |
| dc.description.abstract | Given the presence of antimicrobial activity for various tetrazole derivatives and its condensed analogues, it was proposed to analyze 13 novel 5-phenyl-5,6-dihydrotetrazolo[1,5-c]quinazolines for molecular docking to ribosomal 50S protein L2P (2QEX) in comparison with Tedizolid, tetrazole-oxazolidinone antibiotic. Hence, 4-(5-methyl-5,6-dihydrotetrazolo[1,5-c]-quinazolin-5-yl)benzoic acid 12 proved to be the most probable in terms of antimicrobial activity in vitro as a result of in silico molecular docking to antimicrobial 2QEX target. | uk_UK |
| dc.identifier.citation | Molecular docking of 5-phenyl-5,6-dihydrotetrazolo-[1,5-c]quinazolines to ribosomal 50s protein L2P (2QEX) / O. Antypenko, L. Antypenko, D. Kalnysh, S. Kovalenko // Міжнародний науковий журнал «Грааль науки». – 2022. - № 12-13.- С. 693-698. | uk_UK |
| dc.identifier.uri | https://zsmu.rosbai.com/handle/123456789/17560 | |
| dc.language.iso | en | uk_UK |
| dc.subject | 5-phenyl-5,6-dihydrotetrazolo[1,5-c]quinazolines | uk_UK |
| dc.subject | molecular docking | uk_UK |
| dc.subject | ribosomal 50S protein L2P (2QEX) | uk_UK |
| dc.title | Molecular docking of 5-phenyl-5,6-dihydrotetrazolo-[1,5-c]quinazolines to ribosomal 50s protein L2P (2QEX | uk_UK |
| dc.type | Article | uk_UK |